Figure 2.
Sensitivity analysis: OS from ELIANA (enrolled tisagenlecleucel) vs MT103-205 (blinatumomab).

Sensitivity analysis: OS from ELIANA (enrolled tisagenlecleucel) vs MT103-205 (blinatumomab).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal